| Entry |
|
|---|
| Name |
Pegdinetanib (USAN/INN) |
|---|
| Formula |
C468H729N125O139S
|
|---|
| Exact mass |
10356.3539
|
|---|
| Mol weight |
10362.62
|
|---|
| Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
|---|
| Efficacy |
Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor |
|---|
| Comment |
PEGylated peptide
angiogenesis inhibitor
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
D09945 Pegdinetanib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
VEGFR family
VEGFR2 (KDR)
D09945 Pegdinetanib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
